Clinical trial
Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
NCT00004689 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
- Lead sponsor
- National Jewish Health
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 1991
- Completion date
- September 30, 1998
- Enrollment
- 50
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.